This page is currently under construction
The Centre for Studies of Immune Regulation has been selected as a Centre of Excellence by The Research Council of Norway, starting in 2007.
There are five member-groups, Bakke-group, Bogen-group, Johansen-group,
Sandlie-group and Sollid-group. All groups are located at The University of Oslo.
History. The three clinical immunology-oriented groups and the two basic
immunology/technology-oriented groups have been engaged in extensive
interaction through the Centre for Vaccinology and Immunotherapy (CEVI). CEVI
was established in 2001 as a thematic research group in the Faculty of
Medicine, University of Oslo, based on top evaluation among 37 applications. In 2005, CEVI
received another excellent evaluation, and its mandate was extended. CEVI has
organised an annual one-day synergy seminar emphasizing project presentation by
doctoral students and postdocs to promote student-initiated collaboration.
scientific goal of the Centre is to identify mechanisms of immune dysregulation
that contribute to autoimmune and allergic disease. Three models of autoimmune
and allergic disease will be studied in detail to identify novel mechanisms
amenable to therapeutic intervention. Applying this information, we will
develop and implement innovative agents for use in immune intervention and
therapy. This work will involve a combination of basic research, research using
animal and human disease models, and student training, all of which will be
carried out by the multidisciplinary Centre. The Centre will be a collaborative
of two technology-oriented groups and three clinical immunology-oriented groups
in a University Hospital environment. The five
groups have complementary expertise and together possess an extensive array of
state-of-the-art technologies that are integral to the studies. The Centre will
also bring in leading scientists from abroad.